Ypsomed Holding AG

SWX-YPSN
SIX Swiss Exchange
Healthcare Medical Instruments & Supplies
Global Rank
#2512
Country Rank
#52
Market Cap
7.43 B
Price
544.16
Change (%)
0.69%
Volume
9,964

Ypsomed Holding AG's latest marketcap:

7.43 B

As of 07/26/2025, Ypsomed Holding AG's market capitalization has reached $7.43 B. According to our data, Ypsomed Holding AG is the 2512th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 7.43 B
Revenue (ttm) 942.21 M
Net Income (ttm) 110.1 M
Shares Out 13.65 M
EPS (ttm) 8.06
Forward PE 28.96
Ex-Dividend Date 07/04/2025
Earnings Date 11/12/2025
Market Cap Chart
Data Updated: 07/26/2025

Ypsomed Holding AG's yearly market capitalization.

Ypsomed Holding AG has seen its market value grow from ₣1.08 B to ₣5.9 B since 2014, representing a total increase of 444.96% and an annual compound growth rate (CAGR) of 17.39%.
Date Market Cap(₣) Market Cap(USD) Change (%) Global Rank
07/26/2025 ₣5.9 B $7.43 B 32.94% 2512
12/30/2024 ₣4.47 B $4.92 B 8.09% 3029
12/29/2023 ₣4.14 B $4.91 B 79.49% 2904
12/30/2022 ₣2.3 B $2.49 B -2.23% 4606
12/30/2021 ₣2.36 B $2.58 B 26.18% 5239
12/30/2020 ₣1.87 B $2.11 B 13.13% 5147
12/30/2019 ₣1.65 B $1.7 B 12.93% 5031
12/28/2018 ₣1.46 B $1.49 B -27.87% 4830
12/29/2017 ₣2.03 B $2.08 B -13.14% 4473
12/30/2016 ₣2.33 B $2.29 B 27.53% 3594

Company Profile

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, specializes in the development, manufacturing, and sale of injection and infusion systems for pharmaceutical and biotechnology companies. Headquartered in Burgdorf, Switzerland, the company was established in 1984 and operates globally.

Business Segments

  • Ypsomed Delivery Systems – Provides innovative injection solutions, including:
    • Pen injectors
    • Auto injectors
    • Wearable injectors
    • Smart devices
    Products are marketed under the YDS brand.
  • Ypsomed Diabetes Care – Offers diabetes management solutions, such as:
    • Insulin pumps
    • Infusion sets
    • Pen needles
    • Blood glucose monitoring systems
    • Accessories
    Products are sold under the mylife brand.

Additional Services

The company also provides precision turned parts, contract manufacturing, and other specialized services.

Distribution Network

Ypsomed markets its products through:

  • Pharmaceutical partners
  • Own distribution network
  • Independent distributors

Global Presence

Ypsomed operates in Switzerland, Europe, North America, and other international markets.

Frequently Asked Questions

  • What is Ypsomed Holding AG's (SWX-YPSN) current market cap?
    As of 07/26/2025, Ypsomed Holding AG (including the parent company, if applicable) has an estimated market capitalization of $7.43 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Ypsomed Holding AG global market capitalization ranking is approximately 2512 as of 07/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.